NAD-related products are sold through very different arrangements: a prescription program, a clinic infusion, or a supplement subscription. A headline expressed “per month” can hide differences in the initial commitment, billing period, and what the payment buys.
The public examples below were checked September 23, 2026. They are starting points for a written quote, not promises about what your prescription or enrollment would cost.
THE USEFUL DISTINCTION
Compare the actual billing term and included services before comparing monthly headline numbers.
CoreAge’s starting figure
CoreAge’s NAD+ injectable page advertises a starting price of $93 per month, no membership fees, and delivery. The product page is a commercial description; it does not establish the final terms for every person, quantity, or plan.
Ask what is charged at enrollment and renewal, which supplies and clinical services are included, and what cancellation changes. Our CoreAge review records the offer and the limits of what we verified. We did not complete a clinical intake or payment.
Evidence: CoreAge Rx: NAD+ injectable product page / CoreAge Rx: public catalog
AgelessRx’s introductory condition
AgelessRx advertises $79 for the first month on a three-month plan billed in full, followed by $149 per month. The first-month figure should not be presented as the ongoing monthly price or assumed to be the total amount charged initially.
Confirm the complete first invoice, subsequent term, cancellation timing, and any refund limits in the actual enrollment flow. The AgelessRx review separates these advertised terms from the company’s benefit claims. Both need careful reading, for different reasons.
Evidence: AgelessRx: NAD+ injections
A supplement is another purchase category
Elysium Basis is an oral NR-plus-pterostilbene supplement, not a shipped NAD+ prescription or an infusion appointment. Its subscription terms distinguish monthly and prepaid arrangements; prepaid commitments can have different cancellation and refund consequences.
Our Basis review discusses those terms without presenting capsules and sterile preparations as interchangeable treatments. A lower price for a different intervention does not prove better value for a clinical goal that has not been established.
Evidence: Elysium: Basis product and subscription terms / Dellinger et al.: 2017 NRPT randomized trial
Ask what the payment leaves out
A clinic may charge separately for assessment, administration, or follow-up. A prescription program may have plan-specific quantities and renewal rules. Ask which clinician handles concerns and whether additional evaluation could create another charge.
Read the route comparison and safety explanation before choosing on cost alone. No price, discount, or subscription benefit resolves the uncertainty about long-term outcomes or the suitability of an injectable product for you.
Evidence: FDA: suitable ingredients for sterile compounding / FDA: compounding and approval / AgelessRx: NAD+ injections
Open the source material
- CoreAge Rx: NAD+ injectable product page
Commercial description and starting price checked September 23, 2026. Benefit claims are not independent efficacy evidence.
- CoreAge Rx: public catalog
Company-level context and advertised offerings; no patient enrollment performed.
- AgelessRx: NAD+ injections
Advertised $79 first month on a three-month plan billed in full, then $149 per month. Confirm final terms; surveys are not controlled trials.
- Elysium: Basis product and subscription terms
Oral NR plus pterostilbene supplement, not injectable NAD+. Marketing and purchase terms are separate from clinical trial results.
- Dellinger et al.: 2017 NRPT randomized trial
120 adults aged 60–80, eight weeks; NAD+ biomarker and safety outcomes. Elysium funded the study; not evidence of longer life.
- FDA: suitable ingredients for sterile compounding
Specific NAD+ safety communication: food-grade material, contamination risk and reported adverse events.
- FDA: compounding and approval
Compounded drugs are not FDA-approved; ingredient evidence does not certify the finished preparation.
